MEF2A sequence variants in Turkish population

Gulec S., AKAR A. R., Akar N.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.14, no.4, pp.465-467, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2008
  • Doi Number: 10.1177/1076029607306403
  • Journal Name: CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.465-467
  • Keywords: MEF2A, myocardial infarction, CORONARY-ARTERY-DISEASE, TRANSCRIPTION FACTOR MEF2C, MYOCARDIAL-INFARCTION, NUCLEAR-LOCALIZATION, MUTATIONS, FAMILY, EXPRESSION, FEATURES, DOMAIN
  • Ankara University Affiliated: Yes

Abstract

Myocyte enhancer factor 2 (MEF2) is present in skeletal, cardiac, and smooth muscles and in neurons. MEF2A gene encodes a transcription factor which was on 15q26. The objective was to study the MEF2A gene in patients with premature MI. The control group consisted of 87 subjects who were older than 45 years with no history of cardiovascular disease or MI and no family history of CAD. The premature MI group consisted of 69 patients with documented MI younger than 45 years. No abnormal bands with single strand conformation polymorphism were detected after screening exon 1 through exon 8. This is the first study that detected 145408: T > C polymorphism in intron 10. In both study groups, the rare polymorphism P279L in exon 7, T > C polymorphism in intron 10, and 21-bp deletion in exon I I of the gene were not found. The data supported the previous studies indicating no association between MEF2A gene and premature MI.